Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation

M Yu, M Liu, W Zhang, Y Ming - Current drug metabolism, 2018 - ingentaconnect.com
Background: Tacrolimus (Tac, or FK506), a calcineurin inhibitor (CNI), is the first-line
immunosuppressant which consists of the footstone as immunosuppressive regimens in …

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in …

K Kurose, E Sugiyama, Y Saito - Drug metabolism and …, 2012 - jstage.jst.go.jp
Drug lag, recently discussed extensively in Japan, can be divided into two phases: clinical
development time and application review time. The former factor is still an important problem …

Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations

JT Tang, LM Andrews, T van Gelder… - Expert opinion on …, 2016 - Taylor & Francis
ABSTRACT Introduction: Tacrolimus (Tac) is effective in preventing acute rejection but has
considerable toxicity and inter-individual variability in pharmacokinetics and …

ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population

G Ozbey, B Yucel, SE Taycan, D Kan, NE Bodur… - Pharmacological …, 2014 - Elsevier
Background The ATP-binding cassette sub-family B member 1 (ABCB1) gene, which
encodes the p-glycoprotein at the blood–brain barrier, is investigated for patients' …

免疫抑制剂代谢相关基因多态性检测芯片的研制及其在肝移植患者中的应用

姜楠, 李洋, 胥顺, 傅斌生, 汪国营, 李华, 汪根树… - 器官移植, 2013 - cqvip.com
目的建立一种快速, 准确的检测免疫抑制剂常见代谢相关基因多态性的微阵列芯片技术,
明确肝移植供, 受体细胞色素P450 家族细胞色素3A5 (cytochromeP4503A5, CYP3A5) …

Effects of breviscapine and C3435T MDR1 gene polymorphism on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers

Y Zhao, Z Miao, M Jiang, X Zhou, Y Lai - Xenobiotica, 2021 - Taylor & Francis
Breviscapine (BRE) is usually used for long-term use in patients with cardiovascular
diseases such as coronary heart disease, angina pectoris, and cerebral thrombosis. It is …

Distinct genotype distribution and haplotype profiles in MDR1 gene among Chinese Han, Bai, Wa and Tibetan ethnic groups

Y Lai, M Huang, H Li, XD Wang… - Die Pharmazie-An …, 2012 - ingentaconnect.com
P-Glycoprotein (P-gp, encoded by MDR1 gene) plays an important role in determining
bioavailability and pharmacologic effects of many drugs. There is increasing evidence that P …

Genetic variation of cytochrome P450 in Uyghur Chinese population

G Qi, D Li, X Zhang - Drug Metabolism and Pharmacokinetics, 2018 - Elsevier
Interindividual and interethnic variability of drug responses could be attributed to the
differences of genetic polymorphisms in the drug metabolizing enzymes and transporters …

Pharmacogenetics of Tacrolimus in Solid Organ Transplant Patients

FA Shah, A Ali, Z Bader, G Hassan - Precision Medicine …, 2023 - rootspress.org
Tacrolimus is one of the most important immunosuppressant drugs used in organ
transplants. The primary enzymes responsible for the metabolism of tacrolimus are …

Genetic polymorphisms of the drug-metabolizing enzyme cytochrome P450 3A5 in a Uyghur Chinese population

Z Chen, J Li, P Chen, F Wang, N Zhang, M Yang… - Xenobiotica, 2016 - Taylor & Francis
Detection of CYP3A5 variant alleles, and knowledge about their allelic frequency in Uyghur
ethnic groups, is important to establish the clinical relevance of screening for these …